OverviewChartNewsTraderScreen

BNP Paribas Aktienanleihe SNW 27..../  DE000PC8A5E1  /

EUWAX
5/27/2024  9:47:44 AM Chg.-0.06 Bid2:23:33 PM Ask2:23:33 PM Underlying Strike price Expiration date Option type
100.82EUR -0.06% 100.82
Bid Size: 100,000		 100.92
Ask Size: 100,000		 SANOFI SA INHABER ... 80.00 EUR 3/27/2025 Call
GlobeNewswire 7:00 AM Press Release: Sarclisa accepted for FDA priority review for the treatment of transplant-ineligible ...
GlobeNewswire 5/23 CRISPR Therapeutics Strengthens Executive Leadership Team with Key Appointments
GlobeNewswire 5/21 Press Release: Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration
GlobeNewswire 5/20 Dupixent® (dupilumab) Late-Breaking Data from NOTUS Confirmatory Phase 3 COPD Trial Presented at ATS...
GlobeNewswire 5/20 Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ...
GlobeNewswire 5/20 Shah Capital Withdraws Proxy Campaign Against Re-Election of Directors at Novavax’s 2024 Annual Meet...
GlobeNewswire 5/13 Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 20...
GlobeNewswire 5/13 Fulcrum Therapeutics Enters into a Collaboration and License Agreement with Sanofi for the Developme...
TeleTrader 5/13 Europe mixed at open as CPI prints loom
GlobeNewswire 5/13 Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chroni...
TeleTrader 5/10 Novavax skyrockets 213.5% in premarket, highest in 16 months
TeleTrader 5/10 Novavax soars 39.6% in premarket after Sanofi license deal
GlobeNewswire 5/10 Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVI...
GlobeNewswire 5/9 Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab
TeleTrader 5/9 Europe opens mixed with BoE in focus
GlobeNewswire 5/8 IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 5/7 Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
GlobeNewswire 5/2 Regeneron Reports First Quarter 2024 Financial and Operating Results
GlobeNewswire 5/2 Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant R...
GlobeNewswire 4/30 Press Release: Annual General Meeting of April 30, 2024
TeleTrader 4/25 Europe opens mostly down after corporate earnings
TeleTrader 4/25 Europe down in premarket as financial results pour in
TeleTrader 4/25 Sanofi books net sales of €10.5B in Q1, up 2.4%
GlobeNewswire 4/25 Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance
GlobeNewswire 4/23 Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia